The UAE is preparing to become the first country to approve an oral treatment for vitiligo, according to Dr Ayman Alnaeem, president of the Emirates Dermatology Society, at the opening of a major dermatology meeting in Dubai on Friday, November 6. The announcement came as the 10th Conference of the Dermatology Division of the Emirates Medical Association began at the InterContinental Dubai–Festival City, drawing more than 500 physicians and specialists from different countries.
The three-day conference is focused on new developments in dermatology, with sessions covering artificial intelligence, clinical imaging and emerging treatment methods. Organisers said the programme also includes a wide range of medical topics such as skin aging, eczema, acne, skin cancer, infectious skin diseases and inflammatory skin diseases. Vitiligo, which causes loss of skin pigment when the immune system destroys melanocytes, is among the conditions drawing particular attention at the event.
Dr Alnaeem said the meeting will feature the official launch of the vitiligo treatment, along with the introduction of other new dermatology therapies, including the latest biological treatments for psoriasis. He said these developments reflect the UAE’s growing role in medical and pharmaceutical innovation, and noted that the country is among the faster markets in registering new medicines so patients can access recent treatments.
He also pointed to the UAE’s early use of artificial intelligence in diagnosing skin diseases such as psoriasis and skin cancer, as well as laser applications for vascular birthmarks, pigmentation and benign tumours. In his remarks, he described the country as a destination for innovation, medical knowledge exchange and healthcare excellence, while the conference itself continues to serve as a forum for specialists to discuss both established conditions and newer technologies in dermatology.